Crescent Biopharma, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2017
Total Assets: $128.6M
Liabilities Breakdown FY2017
Total Liabilities: $8.9M
Asset Breakdown
Total Assets: $128.6M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $123.9M | 96.4% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $1.1M | 0.9% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $3.6M | 2.8% |
Liabilities Breakdown
Total Liabilities: $8.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.6M | 29.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $6.2M | 70.2% |